athenex: Intas & Dr Reddy’s in race with PEs to buy US’ Athenex
India's Intas Pharmaceuticals and Dr Reddy's Laboratories are in talks to acquire Athenex Inc in a $200-250 million (₹1,580-1,980 crore) deal, as the US-based biotechnology firm looks to sell a controlling stake. The two Indian pharma…